MAPK8 and Alzheimer disease: As we have reported in our previous study, SCM-198 could inhibit overactivated microglia via JNK and NF-κB pathways, and further studies are needed to confirm whether SCM-198’s effect on these pathways in microglia contribute to the improvement of cognition in AD transgenic mouse models.